Linked research, clinical, and regulatory source pathways.
Company profile
About Ribbon Health
H1 is an AI-powered healthcare intelligence platform that connects the global healthcare ecosystem by providing comprehensive data and analytics about healthcare professionals, clinical trials, and provider networks. The company serves life sciences organizations, health plans, digital health companies, and healthcare providers with solutions that span clinical trial site selection and patient recruitment, medical affairs and KOL engagement, commercial prescriber targeting, and provider directory management. H1's platform aggregates and standardizes healthcare professional data from multiple sources to create detailed profiles including credentials, specialties, clinical trial experience, prescribing patterns, and research publications. For pharmaceutical and biotech companies, H1 accelerates clinical trials through its Site Universe and Patient Universe products, which help identify optimal research sites and improve patient representation. The Medical and Commercial solutions enable life sciences teams to discover key opinion leaders, track HCP engagement, and identify top prescribers with real-time insights. For health plans and digital health companies, H1 provides accurate provider data management through directory automation, roster ingestion, and network adequacy solutions that ensure members can find and access in-network providers. The platform serves over 200 customers across six continents, including 85% of the top 20 pharmaceutical companies and 9 of the top 10 payers. H1 recently received a $40 million investment led by CVS Health Ventures, reflecting the company's position as a critical infrastructure provider for healthcare data intelligence. The company's mission is to create a healthier future by making healthcare information and evidence-based medicine accessible to everyone globally, ultimately closing the gap between patients and the treatments they need.
Company description Ribbon Health official website
Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
No clinical focus areas are currently listed.
Who it serves
- Biotech companies
- Clinical research organizations
- Digital health companies
- Health plans/payers
- Medical device companies
- Pharmaceutical companies
Deployment & integration
Deployment information is currently being developed.
Recorded integration context: Clinical trial management systems, Commercial platforms, Customer CRM systems, Network management systems, Provider directories.
Geographic context
Company milestones
Platform expansion
Received $40M investment in round led by CVS Health Ventures. Serves 200+ customers across 6 continents including 85% of top 20 pharma companies and 9 of top 10 payers.
Partnerships
Recorded partners
- Appy Health
- Bennie
- BioMarin
- CTI Clinical Trial and Consulting Services
- CVS Health Ventures (lead investor, $40M round)
- Health Advocate
- Healthee
- Incyte
- Johnson & Johnson
- Memorial Sloan Kettering
- Worldwide Clinical Trials
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
No source-backed Company products are currently listed.
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
Discrepancies in classification and reporting of restrictive practices (restraints, seclusion and other coercive measures) in mental health services: multi-scenario analysis of an international survey.BJPsych open · May 11, 2026
Diverging views between clinicians, service users, family caregivers and researchers on the classification of restrictive practices in mental health services.Epidemiology and psychiatric sciences · Dec 12, 2025
Strategies for identifying and channeling patients for depression care management.The American journal of managed care · Aug 1, 2008
Clinical validation
Clinical-trial records
No linked records are currently available.
Regulatory
Regulatory records
No linked records are currently available.
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
BioMarin clinical operations
CTI using Site Intelligence
Health Advocate partnership
Health plan customers
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Updates from Ribbon Health
Recent articles published on Ribbon Health's official website.
No Company updates are currently listed.
07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Population Health & Healthcare Analytics
Companies providing AI-powered analytics for population health management, healthcare data integration and analysis, risk stratification, care gap identification, or value-based care analytics. Focuses on analyzing data across patient populations to improve outcomes at scale and enable data-driven decision-making across health systems.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.